Fighting the uphill battle to cure type 1 diabetes.

Beta cell replacement therapy varies depending on the cell sources: allogeneic, or xenogeneic islet; beta-like cells derived from ESCs or iPSCs. There have been many efforts to cure type 1 diabetes, including immunotherapy, artificial pancreas, and beta cell replacement therapy (Figure 1). Beta cell replacement therapy varies depending on the cell sources: allogeneic, or xenogeneic islet; beta-like cells derived from ESCs or iPSCs. [Extracted from the article]